ROSEN, NATIONAL TRIAL COUNSEL, Encourages Brainstorm Cell Therapeutics Inc. Investors with Losses to Secure Counsel Before Important January 2 Deadline in Securities Class Action First Filed by the Firm
- Written by Newsfile
New York, New York--(Newsfile Corp. - December 22, 2023) - WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Brainstorm Cell Therapeutics Inc. (NASDAQ: BCLI) between August 15, 2022 and September 27, 2023, both dates inclusive (the "Class Period"), of the important January 2, 2024 lead plaintiff...